Doctor Anna Sina Pettersson Meyer
(Denmark)
Effects of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan: results from the phase 2 RESCUE-2 trial
Event: ESC Congress 2022
Topic: Renal Failure and Cardiovascular Disease
Session: Renal failure and cardiovascular disease 2
ESC 365 is supported by
